MedTrace Logo

Umbilical Cord Mesenchymal Stem Cells Infusion for Initial Type 1 Diabetes Mellitus

NCT01219465 · Status: UNKNOWN · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2010-10-13

No results posted yet for this study

Summary

The purpose of this study is to determine whether umbilical cord Mesenchymal Stem Cells of treatment for initial type 1 diabetes is safe and effective.

Conditions

Interventions

BIOLOGICAL

umbilical cord mesenchymal stem cells

Transfusion of the umbilical cord mesenchymal stem cells (2 x 107 cells) intravenously.

Sponsors & Collaborators

  • Qingdao University

    lead OTHER

Principal Investigators

  • Yangang Wang, MD Phd · The Affiliated Hospital of Qingdao University

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
3 Years
Max Age
35 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-09-30
Primary Completion
2012-09-30
Completion
2012-12-31

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01219465 on ClinicalTrials.gov